Read Time:6 Second
Bristol Myers Squibb on Friday reported fourth-quarter results that beat analysts’ expectations, helped by portfolio stalwarts as well as newer drugs.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
